Can Farxiga (Dapagliflozin) Cause Diarrhea?
Diarrhea is not a direct adverse effect of Farxiga (dapagliflozin), but the FDA label mentions diarrhea only in the context of fluid loss that can worsen dehydration—a known risk with this medication. 1
Understanding the Relationship
The FDA medication guide for Farxiga specifically instructs patients to contact their healthcare provider if they "start to lose liquids from your body, for example from vomiting, diarrhea, or being in the sun too long" 1. This mention is not identifying diarrhea as a side effect of the drug itself, but rather warning that if diarrhea occurs from any cause, it can compound the volume depletion risk that SGLT2 inhibitors already create.
What This Means Clinically
The key distinction is that Farxiga causes volume depletion through increased urinary glucose and sodium excretion, not through gastrointestinal effects. The primary adverse effects documented in clinical trials and FDA labeling are:
- Genital mycotic infections (most common, especially in women) 2, 3, 4
- Urinary tract infections 2, 5
- Volume depletion/dehydration leading to orthostatic hypotension 1
- Diabetic ketoacidosis (rare but serious) 1
- Fournier's gangrene (rare necrotizing fasciitis of the perineum) 1, 2
Clinical Implications
If a patient on Farxiga develops diarrhea:
- Investigate other causes of diarrhea (infection, dietary changes, other medications, metformin if co-prescribed)
- Monitor closely for dehydration since the combination of SGLT2 inhibitor-induced osmotic diuresis plus diarrhea significantly increases volume depletion risk
- Check kidney function as acute kidney injury has been reported with volume depletion in patients taking Farxiga 1
- Consider temporarily holding Farxiga during acute diarrheal illness until volume status is restored
Important Caveat
If the patient is also taking metformin (a common combination in type 2 diabetes management 6), diarrhea is much more likely attributable to metformin, which causes GI side effects in a substantial proportion of patients 6. The 2025 ADA guidelines specifically note that metformin's GI side effects can be mitigated with slow dose titration, extended-release formulations, and administration with food 6.
Bottom line: Diarrhea should not be attributed to Farxiga itself, but any diarrhea in a patient taking this medication requires prompt attention due to the compounded dehydration risk.